Cargando…

1465. Resistance to Oral Antibiotics Among Urinary Tract Infection Isolates of Escherichia coli from the United States and Europe in 2017

BACKGROUND: Clinical guidelines have recommended oral antibiotics such as the cephalosporins, fluoroquinolones, and trimethoprim-sulfamethoxazole (TMP-SMX) for the treatment of urinary tract infections (UTI’s) caused by Escherichia coli (EC). The utility of these agents continues to be eroded by inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Critchley, Ian A, Cotroneo, Nicole, Sulham, Kate, Melnick, David, Mendes, Rodrigo E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808803/ http://dx.doi.org/10.1093/ofid/ofz360.1329

Ejemplares similares

The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017
por: Critchley, Ian A., et al.
Publicado: (2019)

1695. Tebipenem: An Oral Carbapenem with activity against Multi-drug Resistant Urinary Tract Infection isolates of Escherichia coli collected from US Medical Centers during 2019
por: Critchley, Ian A, et al.
Publicado: (2020)

1254. Molecular Epidemiology of Escherichia coli Causing Urinary Tract Infections in United States and in vitro Activity of Tebipenem, Including Against Strain Lineage and Resistant subsets (2018-2020)
por: Mendes, Rodrigo E, et al.
Publicado: (2021)

1057. Tebipenem In vitro Activity Against a Collection of Pathogens Responsible for Urinary Tract Infections in the US
por: Mendes, Rodrigo E, et al.
Publicado: (2021)

Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019–2020)
por: Mendes, Rodrigo E., et al.
Publicado: (2023)

1041. In vitro activity of tebipenem against a recent collection of fastidious organisms recovered from respiratory tract infections
por: Arends, S J Ryan, et al.
Publicado: (2021)

2159. Analysis of Resistance to Oral Standard-of-Care Antibiotics for Urinary Tract Infections Caused By Escherichia coli and Staphylococcus saprophyticus Collected in the United States in 2022
por: Arends, S J Ryan, et al.
Publicado: (2023)

Community-Acquired Urinary Tract Infection by Escherichia coli in the Era of Antibiotic Resistance
por: Lee, Dong Sup, et al.
Publicado: (2018)

Enteroaggregative Escherichia coli is associated with antibiotic resistance and urinary tract infection symptomatology
por: Martínez-Santos, Verónica I., et al.
Publicado: (2021)

Bacteriological profile of urinary tract infections and antibiotic susceptibility of Escherichia coli in Algeria
por: Ait-Mimoune, Nouara, et al.
Publicado: (2022)

1691. Pre- and Post-Hospitalization Resource Utilization and Costs Associated with Urinary Tract Infection (UTI) in both Commercial and Medicare Populations
por: Melnick, David, et al.
Publicado: (2020)

1416. Medicare Spending on Urinary Tract Infections: A Retrospective Database Analysis
por: Sulham, Kate, et al.
Publicado: (2021)

1062. Analysis of Resistance to Oral Standard of Care Antibiotics for Urinary Tract Infections Caused By Escherichia coli and Staphylococcus saprophyticus Collected Worldwide between 2019-2020
por: Arends, S J Ryan, et al.
Publicado: (2021)

1684. Hospital Costs and Reimbursement in Patients with Resistant Enterobacteriaceae (ENT) Urinary Tract Infection (UTI) in the United States (US): A Multicenter Analysis
por: Melnick, David, et al.
Publicado: (2020)

A Stent Thrombosis 1465 Days After Implantation
por: Ocal Karabay, Kanber, et al.
Publicado: (2011)

1672. Eligibility and Outcomes of Conversion to Oral (PO) Therapy in Patients Hospitalized with Enterobacteriaceae (ENT) Urinary Tract Infection (UTI) in the United States (US): A Multicenter Analysis
por: Melnick, David, et al.
Publicado: (2020)

Antibiotic Resistance in Urinary Isolates of Escherichia coli
por: Abduzaimovic, Amila, et al.
Publicado: (2016)

Growth Rate of Escherichia coli During Human Urinary Tract Infection: Implications for Antibiotic Effect
por: Haugan, Maria Schei, et al.
Publicado: (2019)

Urinary Tract Infection Caused by Capnophilic Escherichia coli
por: Tena, Daniel, et al.
Publicado: (2008)

An Approach to Uropathogenic Escherichia Coli in Urinary Tract Infections
por: Ranjan, K Prabhat, et al.
Publicado: (2010)

Change in the Annual Antibiotic Susceptibility of Escherichia coli in Community-Onset Urinary Tract Infection between 2008 and 2017 in a Tertiary Care Hospital in Korea
por: Kim, Young Jun, et al.
Publicado: (2019)

1439. Epidemiology and 12- Month Antibiotic Use in the Outpatient Setting among Adult Patients with Complicated Urinary Tract Infections: A Retrospective Database Analysis
por: Lodise, Thomas, et al.
Publicado: (2021)

1465 Pigmented Mold Endocarditis – Case Series and Review of the Literature
por: Hoz, Ricardo La, et al.
Publicado: (2014)

Stratification by demographic and clinical data of the antibiotic susceptibility of Escherichia coli from urinary tract infections of the community
por: Grados, Martín C., et al.
Publicado: (2019)

Impact of antibiotic pharmacokinetics in urine on recurrent bacteriuria following treatment of complicated urinary tract infections
por: Melnick, David, et al.
Publicado: (2023)

1670. Clinical Characteristics and Demographics of Patients with Complicated Urinary Tract Infections (cUTI) and Antibiotic Resistance or Treatment Failure: A Retrospective Database Analysis
por: Sulham, Katherine, et al.
Publicado: (2020)

1682. Health Resource Utilization in Patients with Complicated Urinary Tract Infections (cUTI) and Antibiotic Resistance or Treatment Failure: A Retrospective Database Analysis
por: Sulham, Katherine, et al.
Publicado: (2020)

150. Low Propensity for Development of Spontaneous In Vitro Resistance to Tebipenem, Ertapenem and Meropenem Among Enterobacterales Uropathogens
por: VanScoy, Brian D, et al.
Publicado: (2022)

Food Reservoir for Escherichia coli Causing Urinary Tract Infections
por: Vincent, Caroline, et al.
Publicado: (2010)

Food Reservoir for Escherichia coli Causing Urinary Tract Infections
por: Giufrè, Maria, et al.
Publicado: (2010)

How to Make It in the Urinary Tract: A Tutorial by Escherichia coli
por: Jorgensen, Ine, et al.
Publicado: (2012)

Resistance patterns of Escherichia coli causing urinary tract infection
por: Ferdosi-Shahandashti, Elaheh, et al.
Publicado: (2015)

Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020)
por: Arends, S. J. Ryan, et al.
Publicado: (2023)

Bacterial Microcompartment-Mediated Ethanolamine Metabolism in Escherichia coli Urinary Tract Infection
por: Dadswell, Katherine, et al.
Publicado: (2019)

Distribution of Virulence Factors According to Antibiotic Susceptibility among Escherichia coli Isolated from Urinary Tract Infection
por: Derakhshan, S., et al.
Publicado: (2018)

Antibiotic resistance in children with E coli urinary tract infection
por: Russell, Grant
Publicado: (2016)

Descriptive Epidemiology and Outcomes of Hospitalizations With Complicated Urinary Tract Infections in the United States, 2018
por: Zilberberg, Marya D, et al.
Publicado: (2022)

Frequency and Diversity of Hybrid Escherichia coli Strains Isolated from Urinary Tract Infections
por: Nascimento, Júllia A. S., et al.
Publicado: (2021)

1044. In vitro Activity of Tebipenem Against Relevant Clinical Isolates in the Presence of Pulmonary Surfactant
por: Arends, S J Ryan, et al.
Publicado: (2021)

1038. In Vitro Activity of Tebipenem, an Orally Available Carbapenem Agent, Against a Collection of Surveillance Gram-Positive Clinical Isolates
por: Arends, S J Ryan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6m3smf2p0cq2vblqnmfiskqk72